LITFULO 50 mg, gélule — plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 gélule(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930279724 -
CIP7
3027972 -
CIS
62624259 -
Registration number
EU/1/23/1755
What the source publishes
- Holder
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Active ingredients
- RITLÉCITINIB, TOSYLATE DE RITLÉCITINIB
- Form
- gélule
- Package
- plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 gélule(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- prescription réservée aux spécialistes et services PEDIATRIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription réservée aux spécialistes et services DERMATOLOGIE ; liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2023-09-15
- Prescription
- Prescription or restricted
Names this record is found by
- LITFULO 50 mg, gélule — plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 gélule(s)
- LITFULO 50 mg, gélule
- RITLÉCITINIB
- TOSYLATE DE RITLÉCITINIB
Complete source data
{
"cis": "62624259",
"cip7": "3027972",
"form": "gélule",
"name": "LITFULO 50 mg, gélule — plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 gélule(s)",
"cip13": "3400930279724",
"holder": "PFIZER EUROPE MA EEIG (BELGIQUE)",
"routes": [
"orale"
],
"holders": [
"PFIZER EUROPE MA EEIG (BELGIQUE)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "972.76",
"authorisedOn": "2023-09-15",
"compositions": [
{
"name": "RITLÉCITINIB",
"nature": "FT",
"strength": "50 mg",
"linkageNumber": "1",
"substanceCode": "59323",
"dosageReference": "une gélule",
"pharmaceuticalElement": "gélule"
},
{
"name": "TOSYLATE DE RITLÉCITINIB",
"nature": "SA",
"strength": null,
"linkageNumber": "1",
"substanceCode": "69083",
"dosageReference": null,
"pharmaceuticalElement": "gélule"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "prescription réservée aux spécialistes et services PEDIATRIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription réservée aux spécialistes et services DERMATOLOGIE ; liste I",
"dispensingFee": "1.02",
"medicinePrice": "971.74",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "LITFULO 50 mg, gélule",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 gélule(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"30 %"
],
"marketingDeclaredOn": "2024-10-17",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": true,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"RITLÉCITINIB",
"TOSYLATE DE RITLÉCITINIB"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"prescription réservée aux spécialistes et services PEDIATRIE",
"médicament nécessitant une surveillance particulière pendant le traitement",
"prescription réservée aux spécialistes et services MEDECINE INTERNE",
"prescription réservée aux spécialistes et services DERMATOLOGIE",
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/23/1755",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930279724"